Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iradimed (IRMD) Income from Continuing Operations (2016 - 2025)

Iradimed (IRMD) has disclosed Income from Continuing Operations for 13 consecutive years, with 9168958.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations rose 146.33% to 9168958.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 25207000.0 through Dec 2025, up 542.07% year-over-year, with the annual reading at 25207000.0 for FY2025, 542.07% up from the prior year.
  • Income from Continuing Operations for Q4 2025 was 9168958.0 at Iradimed, up from 5576652.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 9168958.0 in Q4 2025, with the low at 19789248.0 in Q4 2024.
  • Average Income from Continuing Operations over 5 years is 2967323.7, with a median of 4158186.5 recorded in 2023.
  • The sharpest move saw Income from Continuing Operations soared 327.39% in 2021, then tumbled 535.92% in 2024.
  • Over 5 years, Income from Continuing Operations stood at 4387412.0 in 2021, then dropped by 16.27% to 3673617.0 in 2022, then grew by 23.58% to 4539686.0 in 2023, then crashed by 535.92% to 19789248.0 in 2024, then soared by 146.33% to 9168958.0 in 2025.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 9168958.0, 5576652.0, and 5773961.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.